Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
- 13 January 1984
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 118 (1), 27-32
- https://doi.org/10.1016/0006-291x(84)91062-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Antitumor effect of a calmodulin antagonist on the growth of solid Sarcoma-180Cancer Letters, 1983
- Characterization of a Triphenylethylene- Antiestrogen-Binding Site on Rat Serum Low Density Lipoprotein*Endocrinology, 1983
- Antiestrogen-Binding Sites Distinct from the Estrogen Receptor: Subcellular Localization, Ligand Specificity, and Distribution in Tissues of the Rat*Endocrinology, 1983
- Interaction of drugs with calmodulin: Biochemical, pharmacological and clinical implicationsBiochemical Pharmacology, 1982
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- Calmodulin Plays a Pivotal Role in Cellular RegulationScience, 1980
- Purification of plant calmodulin by fluphenazine-Sepharose affinity chromatographyBiochemical and Biophysical Research Communications, 1979
- Calmodulin and Its Role in the Second-Messenger SystemCurrent Topics in Cellular Regulation, 1979
- THE COLORIMETRIC DETERMINATION OF PHOSPHORUSJournal of Biological Chemistry, 1925